Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Completed 2Not yet recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3Thoracic 2Gastrointestinal 2Gynecologic 1Classical hematology 1CNS 1

Conditions

Breast Neoplasms 3Ovarian Neoplasms 1Neoplasms 1Fanconi Anemia, Complementation Group D1 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Demography × Breast × Clear all
NCT07179809 2025-09-18

Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer

M.D. Anderson Cancer Center

Phase NA Not yet recruiting
100 enrolled
Breast

Breast Neoplasms

NCT03346161 2019-09-06

Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach

Washington University School of Medicine

Phase 1 Completed
120 enrolled 19 charts
Breast

Breast Neoplasms

NCT00776958 2014-07-31

Lynne Cohen Consortium Project: Multi-Center Database/Registry

M.D. Anderson Cancer Center

Completed
176 enrolled
BreastClassical hematologyGynecologic

Fanconi Anemia, Complementation Group D1, Breast Neoplasms, Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡